Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Qiagen (QGEN) EBT (2016 - 2025)

Historic EBT for Qiagen (QGEN) over the last 17 years, with Q4 2025 value amounting to $109.2 million.

  • Qiagen's EBT fell 1325.6% to $109.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $490.3 million, marking a year-over-year increase of 30468.6%. This contributed to the annual value of $490.3 million for FY2025, which is 30468.6% up from last year.
  • Qiagen's EBT amounted to $109.2 million in Q4 2025, which was down 1325.6% from $134.7 million recorded in Q3 2025.
  • In the past 5 years, Qiagen's EBT ranged from a high of $195.5 million in Q1 2022 and a low of -$223.5 million during Q2 2024
  • Moreover, its 5-year median value for EBT was $117.7 million (2023), whereas its average is $107.4 million.
  • Its EBT has fluctuated over the past 5 years, first skyrocketed by 24341.34% in 2021, then crashed by 31839.3% in 2024.
  • Quarter analysis of 5 years shows Qiagen's EBT stood at $165.4 million in 2021, then plummeted by 36.0% to $105.8 million in 2022, then increased by 12.32% to $118.9 million in 2023, then increased by 5.87% to $125.9 million in 2024, then dropped by 13.26% to $109.2 million in 2025.
  • Its EBT was $109.2 million in Q4 2025, compared to $134.7 million in Q3 2025 and $126.8 million in Q2 2025.